Vinod K Batra1, Khadijeh S Alnajjar2, Joann B Sweasy2, Charles E McKenna3, Myron F Goodman4, Samuel H Wilson1. 1. Genome Integrity and Structural Biology Laboratory, National Institute of Environmental Health Sciences, National Institutes of Health, 111 T. W. Alexander Drive, Research Triangle Park, North Carolina 27709, United States. 2. Department of Therapeutic Radiology and Genetics, Yale University School of Medicine, New Haven, Connecticut 06520, United States. 3. Department of Chemistry, University of Southern California, Los Angeles, California 90089-1062, United States. 4. Department of Biological Sciences, University of Southern California, Los Angeles, California 90089-0371, United States.
Abstract
The human DNA polymerase (pol) β cancer variant K289M has altered polymerase activity in vitro, and the structure of wild-type pol β reveals that the K289 side chain contributes to a network of stabilizing interactions in a C-terminal region of the enzyme distal to the active site. Here, we probed the capacity of the K289M variant to tolerate strain introduced within the C-terminal region and active site. Strain was imposed by making use of a dGTP analogue containing a CF2 group substitution for the β-γ bridging oxygen atom. The ternary complex structure of the K289M variant displays an alteration in the C-terminal region, whereas the structure of wild-type pol β is not altered in the presence of the dGTP CF2 analogue. The alteration in the K289M variant impacts the active site, because the enzyme in the ternary complex fails to adopt the normal open to closed conformational change and assembly of the catalytically competent active site. These results reveal the importance of the K289-mediated stabilizing network in the C-terminal region of pol β and suggest an explanation for why the K289M cancer variant is deficient in polymerase activity even though the position 289 side chain is distal to the active site.
The human Dn class="Chemical">NA polymerase (pol) β cancer variant K289M has altered polymerase activity in vitro, and the structure of wild-type pol β reveals that the K289 side chain contributes to a network of stabilizing interactions in a C-terminal region of the enzyme distal to the active site. Here, we probed the capacity of the K289M variant to tolerate strain introduced within the C-terminal region and active site. Strain was imposed by making use of a dGTP analogue containing a CF2 group substitution for the β-γ bridging oxygen atom. The ternary complex structure of the K289M variant displays an alteration in the C-terminal region, whereas the structure of wild-type pol β is not altered in the presence of the dGTPCF2 analogue. The alteration in the K289M variant impacts the active site, because the enzyme in the ternary complex fails to adopt the normal open to closed conformational change and assembly of the catalytically competent active site. These results reveal the importance of the K289-mediated stabilizing network in the C-terminal region of pol β and suggest an explanation for why the K289Mcancer variant is deficient in polymerase activity even though the position 289 side chain is distal to the active site.
Authors: Charles E McKenna; Boris A Kashemirov; Thomas G Upton; Vinod K Batra; Myron F Goodman; Lars C Pedersen; William A Beard; Samuel H Wilson Journal: J Am Chem Soc Date: 2007-11-22 Impact factor: 15.419
Authors: Andrea F Moon; Miguel Garcia-Diaz; Vinod K Batra; William A Beard; Katarzyna Bebenek; Thomas A Kunkel; Samuel H Wilson; Lars C Pedersen Journal: DNA Repair (Amst) Date: 2007-07-12
Authors: Yuan Liu; Rajendra Prasad; William A Beard; Padmini S Kedar; Esther W Hou; David D Shock; Samuel H Wilson Journal: J Biol Chem Date: 2007-03-12 Impact factor: 5.157
Authors: D K Srivastava; B J Berg; R Prasad; J T Molina; W A Beard; A E Tomkinson; S H Wilson Journal: J Biol Chem Date: 1998-08-14 Impact factor: 5.157